-
Modeling Parkinson’s Disease Progression to Quantify Long-Term Treatment Effects via the Concept of ‘Time Saved’
-
Modeling the Genetic Complexity of Parkinson’s Disease: Generation of Patient-Specific iPSCs with Co-occurring SNCA/GBA1 and PRKN/LRRK2 Variants
-
Modifiers of Intergenerational Repeat Changes in X-linked Dystonia–Parkinsonism
-
Modulated functional connectivity in patients with Parkinson’s disease by transcutaneous auricular acupoint Vagus Nerve Stimulation (taVNS)
-
Modulation and subcortical signatures of sleep in Parkinson’s Disease under chronic STN-DBS: insights from Synchronized Deep Brain Sensing and nocturnal videopolysomnography
-
Modulation of Excitatory/Inhibitory Neurotransmission via Targeting GABAA-Gephyrin Signaling: Integrated In-Silico, In-Vitro, and In-Vivo Evidence in Parkinson’s Disease Models
-
Modulation of Finely Tuned Gamma in the Globus Pallidus Internus with Deep Brain Stimulation and Levodopa
-
Modulatory effects of bacterial-derived serine protease on pathological α-synuclein fibrillation in vitro
-
Molecular Profiling of Brain-Derived Extracellular Vesicles and Fluid Biomarkers in Parkinsonism: Distinct Signatures and Clinical Correlates in Progressive Supranuclear Palsy
-
Monitoring Levodopa Responsiveness in Parkinson’s disease using wearable sensors: the digital levodopa challenge
- « Previous Page
- 1
- …
- 123
- 124
- 125
- 126
- 127
- …
- 208
- Next Page »
